PATENT CLAIM ANALYSIS

Application Number: 16140224
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["514", "013200"]

Abstract:
The present invention provides methods for treating inflammatory or autoimmune disease using calcitonin receptor activators, such as calcitonin receptor activating antibodies, among others. The invention also features compositions containing calcitonin receptor activators, methods of diagnosing patients with calcitonin receptor-associated inflammatory or autoimmune disease, and methods of predicting the response of an inflammatory or autoimmune disease or condition in a subject to treatment with calcitonin receptor activators.

Claim (Index 3):
The method of  claim 1 , wherein the inflammatory or autoimmune disease or condition is rheumatoid arthritis, multiple sclerosis, asthma, fibrosis, systemic lupus erythematosus, myasthenia gravis, Sjogren's syndrome, systemic sclerosis, or vasculitis.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.67442
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12122855', '13245279', '13867326', '12735932', '14211784']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7499545052522021
- 35 USC 102 Novelty (BERT): 0.5065969083173919
- Combined Prediction Score: 0.7256187455587211
- Mean Citation Score: 162.286666
- Max Citation Score: 164.1705
- Similarity Product: 89.9882497753501

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test